These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2824102

  • 21. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.
    Engineer DM, Niederhauser U, Piper PJ, Sirois P.
    Br J Pharmacol; 1978 Jan; 62(1):61-6. PubMed ID: 74266
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B.
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inflammatory mediators of asthma.
    Abraham WM, Wanner A.
    Pediatr Pulmonol; 1988 Sep; 4(4):237-47. PubMed ID: 2455882
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bioactive mediators in asthma.
    Smith LJ.
    Chest; 1992 Jun; 101(6 Suppl):381S-384S. PubMed ID: 1317278
    [No Abstract] [Full Text] [Related]

  • 29. [Pharmacology of the leukotrienes].
    Sirois P, Borgeat P.
    J Pharmacol; 1984 Jun; 15 Suppl 1():53-68. PubMed ID: 6328128
    [Abstract] [Full Text] [Related]

  • 30. Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions.
    Jancar S, Braquet P, Sirois P.
    Braz J Med Biol Res; 1987 Jun; 20(5):487-94. PubMed ID: 2838117
    [Abstract] [Full Text] [Related]

  • 31. Arachidonic acid metabolism in inflammation and hypersensitivity reactions: a brief introduction.
    Malmsten CL.
    Cephalalgia; 1986 Jun; 6 Suppl 4():13-6. PubMed ID: 3024843
    [No Abstract] [Full Text] [Related]

  • 32. Leukotrienes: inflammatory mediators--a review.
    White RK, Montgomery S.
    Oral Surg Oral Med Oral Pathol; 1986 May; 61(5):514-8. PubMed ID: 3012436
    [Abstract] [Full Text] [Related]

  • 33. [Leukotrienes and the lung].
    Leitch AG.
    Rev Mal Respir; 1984 May; 1(6):329-36. PubMed ID: 6099600
    [Abstract] [Full Text] [Related]

  • 34. Mast cells and mast cell mediators in models of airway disease.
    Peters SP, Naclerio RM, Freeland HS, Togias A, Schleimer RP, MacGlashan DW, Kagey-Sobotka A, Fox CC, Adkinson NF, Lichtenstein LM.
    Prog Clin Biol Res; 1985 May; 199():153-61. PubMed ID: 2999818
    [No Abstract] [Full Text] [Related]

  • 35. [Mediators of immediate anaphylactic reactions].
    Damas J.
    Rev Med Liege; 1985 Oct 15; 40(20):687-92. PubMed ID: 3003859
    [No Abstract] [Full Text] [Related]

  • 36. The role of lipid mediators in asthma (current views and perspectives).
    König W, Schönfeld W, Knöller J, Köller M.
    Allergol Immunopathol (Madr); 1988 Oct 15; 16(5):289-98. PubMed ID: 3147587
    [Abstract] [Full Text] [Related]

  • 37. Lipid-derived and other chemical mediators of inflammation in the lung.
    Henderson WR.
    J Allergy Clin Immunol; 1987 Apr 15; 79(4):543-53. PubMed ID: 3031147
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.